NCT06714136View on ClinicalTrials.gov

The Role of miRNA in Group 3 Pulmonary Hypertension

Active, not recruitingOBSERVATIONAL

Enrollment

27

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2024

Conditions

Pulmonary Hypertension

Trial Locations (1)

40138

IRCCS AOU Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER